CPXM2
Inactive carboxypeptidase-like protein X2
Also known as: CPX2, CPXM2_HUMAN, UNQ676
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N436
- Gene
- CPXM2
- Ensembl
- ENSG00000121898
- Chromosome
- 10
- Canonical length
- 756 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
Predicted to enable metallocarboxypeptidase activity and zinc ion binding activity. Predicted to be involved in proteolysis. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
756 residues, UniProt reviewed canonical sequence.
>Q8N436|CPXM2
1 MSRPGTATPA LALVLLAVTL AGVGAQGAAL EDPDYYGQEI WSREPYYARP EPELETFSPP
61 LPAGPGEEWE RRPQEPRPPK RATKPKKAPK REKSAPEPPP PGKHSNKKVM RTKSSEKAAN
121 DDHSVRVARE DVRESCPPLG LETLKITDFQ LHASTVKRYG LGAHRGRLNI QAGINENDFY
181 DGAWCAGRND LQQWIEVDAR RLTRFTGVIT QGRNSLWLSD WVTSYKVMVS NDSHTWVTVK
241 NGSGDMIFEG NSEKEIPVLN ELPVPMVARY IRINPQSWFD NGSICMRMEI LGCPLPDPNN
301 YYHRRNEMTT TDDLDFKHHN YKEMRQLMKV VNEMCPNITR IYNIGKSHQG LKLYAVEISD
361 HPGEHEVGEP EFHYIAGAHG NEVLGRELLL LLVQFVCQEY LARNARIVHL VEETRIHVLP
421 SLNPDGYEKA YEGGSELGGW SLGRWTHDGI DINNNFPDLN TLLWEAEDRQ NVPRKVPNHY
481 IAIPEWFLSE NATVAAETRA VIAWMEKIPF VLGGNLQGGE LVVAYPYDLV RSPWKTQEHT
541 PTPDDHVFRW LAYSYASTHR LMTDARRRVC HTEDFQKEEG TVNGASWHTV AGSLNDFSYL
601 HTNCFELSIY VGCDKYPHES QLPEEWENNR ESLIVFMEQV HRGIKGLVRD SHGKGIPNAI
661 ISVEGINHDI RTANDGDYWR LLNPGEYVVT AKAEGFTAST KNCMVGYDMG ATRCDFTLSK
721 TNMARIREIM EKFGKQPVSL PARRLKLRGQ KRRQRGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CPXM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 199 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 199 nTPM
- choroid plexus: 177 nTPM
- colon: 72 nTPM
- epididymis: 57 nTPM
- smooth muscle: 53 nTPM
- ovary: 45 nTPM
Single-cell type
- late spermatids: 563 nCPM
- choroid plexus epithelial cells: 337 nCPM
- distal convoluted tubule cells: 258 nCPM
- early spermatids: 210 nCPM
- epididymal principal cells: 145 nCPM
- peritubular myoid cells: 140 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 172 nTPM
- spinal cord: 43 nTPM
- white matter: 38 nTPM
- medulla oblongata: 35 nTPM
- midbrain: 23 nTPM
- thalamus: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.17
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Coagulation factor 5/8, C-terminal domain
- Peptidase M14, carboxypeptidase A
- Carboxypeptidase-like, regulatory domain superfamily
- Galactose-binding-like domain superfamily
- Peptidase M14 domain-containing protein
- Zinc carboxypeptidases, zinc-binding region 1
- Zinc carboxypeptidase
- F5/8 type C domain
- Carboxypeptidase regulatory-like domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CPXM2 as an antibody target. Whether an autoantibody or antibody against CPXM2 could matter depends on whether native CPXM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CPXM2 is annotated as secreted, so native CPXM2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CPXM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...